| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 |
| filingDate |
2020-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc4bb1f2e42feb7933684a47b3741972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2d2c1cd15dbc441404b5276893112a |
| publicationDate |
2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020215018-A1 |
| titleOfInvention |
Gold(I) And Platinum(II) With Isocyanide Ligand Complexes: Synthesis And Biological Activity |
| abstract |
A method of treating cancer which comprises administering to a cancer patient a therapeutically effective amount of a gold or platinum based drug that has less toxicity and a different mechanism of action to kill the tumor cells than cisplatin. |
| priorityDate |
2019-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |